Man Group PLC Enovis Corp Transaction History

Man Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.44 - $63.8 $827,719 - $952,534	14,930 Added 159.36%	24,299 $1.52 Million
Q4 2023 Feb 14, 2024	BUY	$43.67 - $57.07 $409,144 - $534,688	9,369 New	9,369 $524,000
Q2 2023 Aug 14, 2023	BUY	$52.7 - $64.12 $1.24 Million - $1.51 Million	23,578 Added 140.29%	40,385 $2.59 Million
Q1 2023 May 15, 2023	BUY	$49.5 - $65.92 $35,788 - $47,660	723 Added 4.5%	16,807 $899,000
Q4 2022 Feb 14, 2023	SELL	$44.83 - $57.43 $240,826 - $308,513	-5,372 Reduced 25.04%	16,084 $860,000
Q3 2022 Nov 14, 2022	SELL	$46.07 - $60.1 $577,303 - $753,113	-12,531 Reduced 36.87%	21,456 $988,000
Q2 2022 Aug 15, 2022	BUY	$55.0 - $70.47 $1.87 Million - $2.4 Million	33,987 New	33,987 $1.87 Million

310

60.3M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.51B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.